Financial Statements · Financial Reporting
AstraZeneca Eesti OÜ
Official identifier 11733875Record date 31 Dec 2020
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2020
- Period start
- 1 Jan 2020
- Submitted date
- 29 Jun 2021
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 2,745,796 |
| Balance sheet | Cash and cash equivalents | 2,336,214 |
| Balance sheet | Current assets | 2,713,310 |
| Balance sheet | Current liabilities | 558,642 |
| Balance sheet | Equity | 2,187,154 |
| Balance sheet | Share capital at nominal value | 690,246 |
| Balance sheet | Non-current assets | 32,486 |
| Balance sheet | Retained earnings (loss) from previous periods | 1,267,260 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -6,520 |
| Income statement scheme 1 | Labour costs | -1,716,929 |
| Income statement scheme 1 | Revenue | 2,494,087 |
| Income statement scheme 1 | Annual period profit / loss | 162,948 |
| Income statement scheme 1 | Operating profit (loss) | 162,947 |
| Income statement scheme 1 | Profit (loss) before income tax | 162,948 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 1,267,260 |
| Note: Labour costs | Employees | 29 |
| Note: Labour costs | Labour costs | 1,716,929 |
Linked company
Company: AstraZeneca Eesti OÜ